期刊文献+

盐酸文拉法辛缓释剂与帕罗西汀治疗抑郁症的对照研究 被引量:2

下载PDF
导出
摘要 目的:使用盐酸文拉法辛缓释胶囊和帕罗西汀片治疗抑郁症,比较两者对抑郁症的疗效的差异。方法:将105名抑郁症患者随机分为三组,分别使用怡诺思150mg/日、怡诺思75mg/日及帕罗西汀20mg-40mg/日,比较三组间治疗抑郁症的疗效,以HAMD、HAMA减分率作为疗效的判断标准。结果:8周后三组间在焦虑症状的控制上无显著性差异,但怡诺思150mg组的起效最快。在抑郁症状的控制上,文拉法辛优于帕罗西汀,且与剂量有关,150mg组的文拉法辛抗抑郁疗效优于75mg组。结论:双通道的抗抑郁剂与单通道的抗抑郁剂在治疗焦虑症状方面相比,疗效大致一致,在抗抑郁治疗方面,前者的疗效优于后者,而且存在明显的量效关系。
出处 《新疆医学》 2008年第12期7-10,共4页 Xinjiang Medical Journal
  • 相关文献

参考文献6

  • 1Baldomero EB, Ubago JG, Cereos CL, et al. Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study. Depress Anxiety. 2005 ;22:68 - 76.
  • 2Rush AJ, Fava M, Winniewski SR, et al. Sequenced Treatment Alternatives to RelieveDepression ( STAR * D ): rationale and design. Control Clin Trials. 2004 ;25 : 119 - 142.
  • 3Michael E. Thase, Richard C. Sheiton, Arifulla Khan. Treatment with Venlafaxine Extended Release After SSRI Nonresponse or Intolerance: A randomized comparison of standard - and higher - dosing strategies. J Clin Psychopharmaeol . 2006 ;26:250 - 258.
  • 4Schweitzer I, Burrows G, Tuckwell V, et al. Sustained response to open -label venlafaxine in drug - resistant major depression. J Clin Psyehopharmacol. 2001 ;21 :185 - 189.
  • 5Calabrese PD, Londborg MD, Shelton ME. Citalopram treatment of fluoxetine - intolerant depressed patients. J Clin Psychiatry. 2003 ;64:562 - 567.
  • 6Thase ME, Ferguson JM, Lydiard RB, et al. Citalopram treatment of paroxetine - intolerant depressed patients. Depress Anxiety. 2002 ; 16 : 128 - 133.

同被引文献22

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部